Patents by Inventor Thomas Stabingis

Thomas Stabingis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7307091
    Abstract: The invention discloses deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts. Furthermore, the invention concerns the use of deuterated 3-piperidinopropiophenones for the treatment of muscular illnesses as well as for the preparation of pharmaceutical drugs for the treatment of muscular illnesses. In addition, the invention discloses pharmaceutical formulations containing deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts for the treatment of muscular illnesses in addition to containing pharmaceutically tolerated adjuvants and/or additives.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: December 11, 2007
    Assignee: BDD Berolina Drug Development GmbH
    Inventors: Rudolf-Gisbert Alken, Thomas Stabingis
  • Publication number: 20040242887
    Abstract: The invention discloses deuterated N-substituted &agr;,&agr;-diphenyl &agr;-alkoxy acetic acid aminoalkyl esters as well as the physiologically tolerated salts thereof. Furthermore, the invention concerns the use of deuterated N-substituted &agr;,&agr;-diphenyl &agr;-alkoxy acetic acid aminoalkyl esters for the treatment of hypertonic functional states in the region of the urinary bladder as well as for the preparation of pharmaceutical drugs for the treatment of hypertonic functional states in the region of the urinary bladder.
    Type: Application
    Filed: July 22, 2004
    Publication date: December 2, 2004
    Inventors: Rudolf-Giesbert Alken, Johann Roither, Wolf-Dietrich Hubner, Werner Hrachowina, Thomas Stabingis
  • Publication number: 20040186136
    Abstract: The invention discloses deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts. Furthermore, the invention concerns the use of deuterated 3-piperidinopropiophenones for the treatment of muscular illnesses as well as for the preparation of pharmaceutical drugs for the treatment of muscular illnesses.
    Type: Application
    Filed: May 7, 2004
    Publication date: September 23, 2004
    Inventors: Rudolf-Gisbert Alken, Thomas Stabingis